The pharmaceutical industry is under pressure from all sides to change the way drugs are priced: pricing a medication based on the quality or benefit it provides rather than how many pills or vials are sold. Take a look at how this affects countries all over the globe, here. (Source: Ben Hirschler, […]
Do You Have a Manuscript to Fit ISPOR’s ViHRI?
Are you writing a manuscript on health policy analysis, original health care research, or other health-related topics focusing on Asia, Latin America, or Central and Eastern Europe, Western Asia and Africa (CEEWAA)? If so, ISPOR's region-specific scientific peer-reviewed journal, Value in Health […]
Asia Sees Growth in Medical Writing Due to Outsourcing
Overall growth in outsourcing in clinical research organizations (CROs) has led to the development of medical writing hubs in China, Japan and India. Take a closer look at this emerging profession in each of these locations, here. (Source: Dr Julia Cooper, PAREXEL) […]
ISPOR’s Value in Health Regional Issues Focusing on Asia – Now Available
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Volume 6, focusing on Asia, is now available online. Issue Highlights include: How Quality of Life as Patient Reported Outcome Has Been Studied for Rheumatoid Arthritis in Chinese Speaking Population Reimbursement Coverage […]
News Across Asia – Assuring Quality Health Care Delivery in Asia
Guk-Hee Suh, PhD, discusses the obstacles to quality health care delivery in Asia; Jiuhong Wu, discusses policy changes needed for the advancement of health care services in China and what role Pharmacoeconomics and Health Outcomes Research will play in that; and Nicky Liebermann, MD, discusses […]
How to Make Sure Your Manuscript Gets Accepted for Publication
Co-Editor-in-Chief of the Asia region for Value in Health Regional Issues provides guidance on how to write a excellent manuscript for submission to the journal for publication. This is Part 1 or a four-part series. Is the topic interesting? Is the manuscript written eloquently and coherently? Is it […]
The State of Cost-Utility Analysis in Asia
A data analysis from the Tufts Medical Center Cost-Effectiveness Analysis Registry. Take a look at cost-utility analyses (CUAs) features such as country of study, disease area researched, study funder, and type of intervention. Read more here. (Source: Teja Thorat, Tufts Medical Center, 4/6/15) […]
News Across Asia, Winter 2014 – Now Available
The ISPOR Asia Consortium recently released Volume 3 No.4 Winter 2014 of News Across Asia, covering outcomes research and health policy trends in Asia and activities of the ISPOR Asia Consortium and ISPOR Regional Chapters. Highlights from this issue include: Editorial: Patient-Centeredness […]
ISPOR Asia Consortium Policy Brief On Quality Of Care
Read ISPOR Asia Consortium's policy brief on "Quality of Care" which aims to provide guidance for policy-makers in low and middle-income countries (LMICs) in the Asia-Pacific region on actions that governments can take to Consortium. See more here. (Source: Asia Pacific Observatory on Health Systems […]
Mapi Completes Acquisition of select Optum Life Sciences Services
Mapi is expanding its team with the acquisition of select Optum Life Sciences services, including North American and European Regulatory Consulting, Late Phase CRO and European Health Economics and Outcomes Research (HEOR) teams. Read more here. (Source: PR Newswire, 1/6/15) […]
